JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 9, 2003; DOI: 10.1124/jpet.103.052753


0022-3565/03/3072-776-784$20.00
JPET 307:776-784, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.052753v1
307/2/776    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomsen, M. B.
Right arrow Articles by Vos, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomsen, M. B.
Right arrow Articles by Vos, M. A.

CARDIOVASCULAR

Electrophysiological Safety of Sertindole in Dogs with Normal and Remodeled Hearts

Morten B. Thomsen, Paul G. A. Volders, Milan Stengl, Roel L. H. M. G. Späatjens, Jet D. M. Beekman, Ulrike Bischoff, Morten A. Kall, Kristen Frederiksen, Jørgen Matz, and Marc A. Vos1

Department of Cardiology, Cardiovascular Research Institute Maastricht, Academic Hospital Maastricht, Maastricht, The Netherlands (M.B.T., P.G.A.V., M.S., R.L.H.M.G.S., J.D.M.B., M.A.V.); GENION, Evotec QAI AG, Hamburg, Germany (U.B.); and H. Lundbeck A/S, Copenhagen, Denmark (M.A.K., K.F., J.M.)

Inhibition of the potassium current IKr and QT prolongation are associated with drug-induced torsades de pointes arrhythmias (TdP) and sudden cardiac death. We investigated the cardiac electrophysiological effects of sertindole, an antipsychotic drug reported to prolong the QT interval in schizophrenic patients. In cell cultures, sertindole seemed to be a selective blocker of IHERG over other ion currents. For IHERG, the IC50 value was 64 ± 7 nM, whereas ISCN5A, ICa,L, ICa,T, IKCNQ1/KCNE1, and IKv4.3 were blocked in the micromolar range. In canine ventricular myocytes, the IC50 value for IKr inhibition by sertindole was 107 ± 21 nM. Action potentials in these cells prolonged in a reverse rate- and concentration-dependent manner at 10 to 300 nM sertindole. In vivo, sertindole was administered to anesthetized dogs at clinically relevant (0.05-0.20 mg/kg) and high doses (1.0-2.0 mg/kg) i.v. At 0.05 to 0.20 mg/kg sertindole (plasma concentrations 30-157 nM), QTc was prolonged by 1 to 5% in normal dogs and by 9 to 20% in dogs with remodeled hearts due to chronic atrioventricular block (CAVB). TdP was not induced at these doses in normal dogs or in CAVB dogs with reproducible induction of TdP by dofetilide in previous experiments. At 1.0 to 2.0 mg/kg sertindole (plasma concentrations 0.5-3.1 µM), QTc prolonged by 6 to 11% in normal dogs and by 22% in dofetilide-sensitive CAVB dogs. TdP occurred in three of five animals in the latter group. Thus, at high i.v. doses sertindole can pose a serious proarrhythmic risk when electrical remodeling of the ventricles is present. At clinically relevant doses, however, sertindole does not cause TdP in anesthetized dogs with normal or remodeled hearts.


Received April 7, 2003; accepted July 10, 2003.

Address correspondence to: Dr. Paul G. A. Volders, Department of Cardiology, Cardiovascular Research Institute Maastricht, Academic Hospital Maastricht, P.O. Box 5800, NL 6202 AZ, Maastricht, The Netherlands. E-mail: p.volders{at}cardio.azm.nl




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. B. Thomsen, A. Oros, M. Schoenmakers, J. M. van Opstal, J. N. Maas, J. D.M. Beekman, and M. A. Vos
Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation
Cardiovasc Res, February 1, 2007; 73(3): 521 - 530.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. B. Thomsen, P. G.A. Volders, J. D.M. Beekman, J. Matz, and M. A. Vos
Beat-to-Beat Variability of Repolarization Determines Proarrhythmic Outcome in Dogs Susceptible to Drug-Induced Torsades de Pointes
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1268 - 1276.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. B. Thomsen, S. C. Verduyn, M. Stengl, J. D.M. Beekman, G. de Pater, J. van Opstal, P. G.A. Volders, and M. A. Vos
Increased Short-Term Variability of Repolarization Predicts d-Sotalol-Induced Torsades de Pointes in Dogs
Circulation, October 19, 2004; 110(16): 2453 - 2459.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.